Simon Spichak

Simon Spichak

Auto-generated profile, based on publicly available information

Simon Spichak

Independent Researcher, Toronto, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2023 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
JOJesutofunmi A. Omiye
Jesutofunmi A. Omiye
JLJenna C. Lester
Jenna C. Lester
SSSimon Spichak
Simon Spichak
VRVeronica Rotemberg
Veronica Rotemberg
RDRoxana Daneshjou
Roxana Daneshjou
Large language models (LLMs) are being integrated into healthcare systems; but these models may recapitulate harmful, race-based medicine. The objective of this study is to assess whether four commercially available large language models (LLMs) propagate harmful, inaccurate, race-based content when responding to eight different scenarios that check for race-based medicine or widespread misconceptions around race. Questions were derived from discussions among four physician experts and prior work on race-based medical misconceptions believed by medical trainees. We assessed four large language models with nine different questions that were interrogated five times each with a total of 45 responses per model. All models had examples of perpetuating race-based medicine in their responses. Models were not always consistent in their responses when asked the same question repeatedly. LLMs are being proposed for use in the healthcare setting, with some models already connecting to electronic health record systems. However, this study shows that based on our findings, these LLMs could potentially cause harm by perpetuating debunked, racist ideas.

1 January 2019 in Biological Psychiatry
Verified
Journal Article
Closed access
MCMartin G. Codagnone
Martin G. Codagnone
SSSimon Spichak
Simon Spichak
SOSiobhain M. O’mAhony
Siobhain M. O’mAhony
OOOlivia F. O’lEary
Olivia F. O’lEary
GCGerard Clarke
Gerard Clarke
JCJohn F Cryan
John F Cryan

6 August 2021 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
SSSimon Spichak
Simon Spichak
FDFrancisco Donoso
Francisco Donoso
GMGerard M. Moloney
Gerard M. Moloney
EGEoin Gunnigle
Eoin Gunnigle
JBJillian M. Brown
Jillian M. Brown
JCJohn F Cryan
John F Cryan
Recent investigations in neuroscience implicate the role of microbial-derived metabolites, such as short-chain fatty acids (SCFAs) in brain health and disease. The SCFAs acetate, propionate and butyrate have pleiotropic effects within the nervous system. They are crucial for the maturation of the brain's innate immune cells, the microglia, and modulate other glial cells through the aryl-hydrocarbon receptor. Investigations in preclinical and clinical models find that SCFAs exert neuroprotective and antidepressant affects, while also modulating the stress response and satiety. However, many investigations thus far have not assessed the impact of sex on SCFA activity. Our novel investigation tested the impact of physiologically relevant doses of SCFAs on male and female primary cortical astrocytes. We find that butyrate (0–25 ​μM) correlates with increased Bdnf and Pgc1-α expression, implicating histone-deacetylase inhibitor pathways. Intriguingly, this effect is only seen in females. We also find that acetate (0–1500 ​μM) correlates with increased Ahr and Gfap expression in males only, suggesting immune modulatory pathways. In males, propionate (0–35 ​μM) correlates with increased Il-22 expression, further suggesting immunomodulatory actions. These findings show a novel sex-dependent impact of acetate and butyrate, but not propionate on astrocyte gene expression.

14 October 2017 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
AOAdeoye A. Oyefiade
Adeoye A. Oyefiade
SAStephanie Ameis
Stephanie Ameis
JLJason P. Lerch
Jason P. Lerch
CRConrad Rockel
Conrad Rockel
KSKamila U. Szulc
Kamila U. Szulc
DMDonald J. Mabbott
Donald J. Mabbott